EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ST6GAL1‐Mediated Sialylation Stabilizes PD‐L1 and Drives Immunosuppressive Tumor Microenvironment in Colorectal Cancer

Ximo Xu, Jingyi Liu, Wei Qin, Chengsheng Ding, Zhenghao Cai, Duohuo Shu, Hao Zhong, Yanyan Hu, Mengqin Yu, Leqi Zhou, Jianwen Li, Minhua Zheng und 4 weitere

Advanced Science · 2025-11 · 12 (42)

DOI: 10.1002/advs.202406225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.08.2025. Verfasst von Ximo Xu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, No.197, Ruijin Er Road, Shanghai, 200025, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Microenvironment, B7-H1 Antigen, Sialyltransferases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Major Science and Technology Infrastructure of Translational Medicine (Shanghai), General Program of the Natural Science Foundation of Shanghai Science and Technology Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abnormal glycogene expression is a recognized cancer hallmark, but its impact on the colorectal cancer (CRC) tumor microenvironment (TME) remains unclear. Utilizing bioinformatics analysis on TCGA and GEO datasets, a seven‐glycogene signature is identified for precise glycogene‐based classification in CRC. ST6GAL1, a key focus, emerges as a significant predictor of poor prognosis, with its upregulation linked to unfavorable outcomes in CRC. Functional experiments demonstrate that loss of ST6GAL1 inhibits CRC proliferation, migration, invasion, and metastasis. ST6GAL1‐mediated sialylation of PD‐L1 is critical for maintaining its stability in colorectal cancer cells, and ST6GAL1 knockdown leads to reduced protein stability and increased ubiquitination. ST6GAL1 knockdown in MC38 tumor‐bearing mice enhances the antitumor effect of anti‐PD‐L1 therapy, resulting in smaller tumor sizes and reduced tumor volume compared to control groups. Single‐cell analysis reveals ST6GAL1's influence on immune cell composition in the TME, particularly affecting CD8 + T cells. Taken together, ST6GAL1 is confirmed to act as an important regulating factor in CRC development through immune response and TME composition and has the potential to serve as a novel biomarker in CRC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsTumor MicroenvironmentB7-H1 AntigenSialyltransferasesAntigens, CDAnimalsHumansMiceCell Line, TumorCell Proliferationbeta-D-Galactoside alpha 2-6-Sialyltransferase

Stichwörter der Autor:innen

ST6GAL1colorectal cancerglycogenesimmunotherapysialylation

Substanzen

B7-H1 AntigenSialyltransferasesST6GAL1 protein, humanCD274 protein, humanAntigens, CDbeta-D-Galactoside alpha 2-6-Sialyltransferase

Autor:innen und Institutionen

  • Department of General Surgery, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, No.197, Ruijin Er Road, Shanghai, 200025, China.
  • Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No.80/90, Wujin Road, Shanghai, 200080, China.
  • Department of General Surgery, Shanghai Changhai Hospital, No.168, Changhai Road, Yangpu District, Shanghai, China.
  • Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai JiaoTong University School of Medicine, Shanghai JiaoTong University, No. 280, Chongqing Nan Road, Shanghai, 200031, China.

ORCID-Profile: Bo Feng

Förderung

  • National Natural Science Foundation of China
  • National Major Science and Technology Infrastructure of Translational Medicine (Shanghai)
  • General Program of the Natural Science Foundation of Shanghai Science and Technology Committee
  • National Major Science and Technology Projects of China
  • Youth Medical Talents - Specialist Program

Zitieren

APA

Xu, X., Liu, J., Qin, W., Ding, C., Cai, Z., Shu, D., Zhong, H., Hu, Y., Yu, M., Zhou, L., Li, J., Zheng, M., Li, B., Zhang, S., Yang, X., & Feng, B. (2025). ST6GAL1‐Mediated Sialylation Stabilizes PD‐L1 and Drives Immunosuppressive Tumor Microenvironment in Colorectal Cancer. Advanced Science, 12(42). https://doi.org/10.1002/advs.202406225

Vancouver

Xu X, Liu J, Qin W, Ding C, Cai Z, Shu D, et al. ST6GAL1‐Mediated Sialylation Stabilizes PD‐L1 and Drives Immunosuppressive Tumor Microenvironment in Colorectal Cancer. Advanced Science. 2025;12(42). doi:10.1002/advs.202406225

BibTeX
@article{Xu2025,
  author = {Xu, Ximo and Liu, Jingyi and Qin, Wei and Ding, Chengsheng and Cai, Zhenghao and Shu, Duohuo and Zhong, Hao and Hu, Yanyan and Yu, Mengqin and Zhou, Leqi and Li, Jianwen and Zheng, Minhua and Li, Bin and Zhang, Sen and Yang, Xiao and Feng, Bo},
  title = {ST6GAL1‐Mediated Sialylation Stabilizes PD‐L1 and Drives Immunosuppressive Tumor Microenvironment in Colorectal Cancer},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {42},
  doi = {10.1002/advs.202406225}
}
Kostenlos starten →